rs28933990

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000326.5(RLBP1):​c.700C>T​(p.Arg234Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000661 in 1,436,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

RLBP1
NM_000326.5 missense

Scores

13
5
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 4.29
Variant links:
Genes affected
RLBP1 (HGNC:10024): (retinaldehyde binding protein 1) The protein encoded by this gene is a 36-kD water-soluble protein which carries 11-cis-retinaldehyde or 11-cis-retinal as physiologic ligands. It may be a functional component of the visual cycle. Mutations of this gene have been associated with severe rod-cone dystrophy, Bothnia dystrophy (nonsyndromic autosomal recessive retinitis pigmentosa) and retinitis punctata albescens. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a domain CRAL-TRIO (size 161) in uniprot entity RLBP1_HUMAN there are 17 pathogenic changes around while only 1 benign (94%) in NM_000326.5
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.963
PP5
Variant 15-89210794-G-A is Pathogenic according to our data. Variant chr15-89210794-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13100.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-89210794-G-A is described in Lovd as [Pathogenic]. Variant chr15-89210794-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RLBP1NM_000326.5 linkc.700C>T p.Arg234Trp missense_variant Exon 8 of 9 ENST00000268125.10 NP_000317.1 P12271
RLBP1XM_011521870.3 linkc.700C>T p.Arg234Trp missense_variant Exon 8 of 9 XP_011520172.1 P12271
RLBP1XM_047432927.1 linkc.700C>T p.Arg234Trp missense_variant Exon 6 of 7 XP_047288883.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RLBP1ENST00000268125.10 linkc.700C>T p.Arg234Trp missense_variant Exon 8 of 9 1 NM_000326.5 ENSP00000268125.5 P12271
RLBP1ENST00000563254.1 linkc.100-30C>T intron_variant Intron 1 of 2 2 ENSP00000454740.1 H3BN92
RLBP1ENST00000567787.1 linkn.*278C>T non_coding_transcript_exon_variant Exon 8 of 8 5 ENSP00000457251.1 H3BTN3
RLBP1ENST00000567787.1 linkn.*278C>T 3_prime_UTR_variant Exon 8 of 8 5 ENSP00000457251.1 H3BTN3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000860
AC:
18
AN:
209368
Hom.:
0
AF XY:
0.0000804
AC XY:
9
AN XY:
111996
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000325
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000189
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000661
AC:
95
AN:
1436926
Hom.:
0
Cov.:
31
AF XY:
0.0000632
AC XY:
45
AN XY:
712324
show subpopulations
Gnomad4 AFR exome
AF:
0.0000605
Gnomad4 AMR exome
AF:
0.0000239
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000844
Gnomad4 FIN exome
AF:
0.0000581
Gnomad4 NFE exome
AF:
0.0000619
Gnomad4 OTH exome
AF:
0.000219
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000502
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.000198
AC:
24

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Sep 04, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The RLBP1 c.700C>T; p.Arg234Trp (rs28933990) variant is reported in several individuals and families with retinal dystrophy (Burstedt 1999, Granse 2001, Hipp 2015, Morimura 1999, Nakamura 2005). The variant is reported as pathogenic in ClinVar (Variation ID: 13100) and is reported in the general population with an overall allele frequency of 0.009% (18/209,368 alleles) in the Genome Aggregation Database. The arginine at codon 234 is highly conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious. Considering available information, this variant is classified as likely pathogenic. References: Burstedt MS et al. Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest Ophthalmol Vis Sci. 1999 Apr;40(5):995-1000. Granse L et al. Electrophysiological findings in two young patients with Bothnia dystrophy and a mutation in the RLBP1 gene. Ophthalmic Genet. 2001 Jun;22(2):97-105. Hipp S et al. Phenotype variations of retinal dystrophies caused by mutations in the RLBP1 gene. Acta Ophthalmol. 2015 Jun;93(4):e281-6. Morimura H et al. Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens. Invest Ophthalmol Vis Sci. 1999 Apr;40(5):1000-4. Nakamura M et al. Novel mutation in RLBP1 gene in a Japanese patient with retinitis punctata albescens. Am J Ophthalmol. 2005 Jun;139(6):1133-5. -

Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 234 of the RLBP1 protein (p.Arg234Trp). This variant is present in population databases (rs28933990, gnomAD 0.02%). This missense change has been observed in individuals with Bothnia retinal dystrophy (PMID: 10102298, 22171637). It is commonly reported in individuals of Swedish ancestry (PMID: 10102298). ClinVar contains an entry for this variant (Variation ID: 13100). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RLBP1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RLBP1 function (PMID: 19846785). For these reasons, this variant has been classified as Pathogenic. -

Retinitis pigmentosa Pathogenic:2
Aug 02, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: RLBP1 c.700C>T (p.Arg234Trp) results in a non-conservative amino acid change to a highly conserved residue (HGMD) located in the CRAL-TRIO lipid binding domain (IPR001251) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.6e-05 in 209368 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in RLBP1 causing Retinitis Pigmentosa (8.6e-05 vs 0.00063), allowing no conclusion about variant significance. c.700C>T has been reported in the literature in multiple individuals affected with Retinitis Pigmentosa or Bothnia dystrophy with strong evidence of cosegregation with disease (Sharon_2019, Burstedt_1999, Kohn_2008), and some were reported as compound heterozygous with another pathogenic variant. These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 31456290, 10102298, 18344446). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Bothnia retinal dystrophy Pathogenic:1
Jun 01, 2001
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

RLBP1-related disorder Pathogenic:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Across a selection of the available literature, the RLBP1 c.700C>T (p.Arg234Trp) missense variant has been identified in a homozygous state in 89 patients and in a compound heterozygous state in 11 patients with RLBP1-related disorders (Burstedt et al. 1999; Morimura et al. 1999; Nakamura et al. 2005; Golovleva et al. 2010; Hipp et al. 2015). The p.Arg234Trp variant was reported in six out of 588 control chromosomes and is reported at a frequency of 0.00047 in the European (non-Finnish) population of the Exome Aggregation Consortium. The crystal structure of the variant protein bound to its endogenous ligand, 11-cis-retinal, was compared with the crystal structure of the wild type protein similarly bound to 11-cis-retinal (He et al. 2009; He et al. 2012). The structural analysis revealed an altered retinoid binding pocket in the p.Arg234Trp variant protein, which resulted in a 5-fold tighter binding of the variant protein to 11-cis-retinal, and hence impaired release, compared to wild type (Golovleva et al. 2003). Based on the collective evidence, the p.Arg234Trp variant is classified as pathogenic for RLBP1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -

Retinitis punctata albescens Pathogenic:1
Jun 01, 2001
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Retinal dystrophy Pathogenic:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.27
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Uncertain
0.58
D
MutationAssessor
Pathogenic
3.1
M
PrimateAI
Uncertain
0.78
T
PROVEAN
Pathogenic
-7.5
D
REVEL
Pathogenic
0.80
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.85
MPC
0.85
ClinPred
0.99
D
GERP RS
1.9
Varity_R
0.93
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28933990; hg19: chr15-89754025; API